Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Nitrendipine

See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Nitrendipine?

Nitrendipine is an investigational drug.

There have been 6 clinical trials for Nitrendipine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2009.

The most common disease conditions in clinical trials are Hypertension, Muscle Hypertonia, and Renal Insufficiency, Chronic. The leading clinical trial sponsors are Katholieke Universiteit Leuven, Merck KGaA, and University of Erlangen-Nürnberg Medical School.

Recent Clinical Trials for Nitrendipine
Clinical Studies by Using Accelerated PDX Model to Screen Drugs for Advanced Solid TumorHaining Health-Coming Biotech Co., Ltd.Phase 2
Treatment of Hypertension in Tibetan Adult PopulationWest China HospitalPhase 4
Sympathetic Nerve Activity in Renal FailureUniversity of Erlangen-Nürnberg Medical SchoolPhase 4

See all Nitrendipine clinical trials

Clinical Trial Summary for Nitrendipine

Top disease conditions for Nitrendipine
Top clinical trial sponsors for Nitrendipine

See all Nitrendipine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.